Morton Munk FUJIFILM Diosynth Biotechnologies

Morten Munk's focus and success in making pharmaceutical products available for patients is founded on more than 30 years of industry experience in biopharmaceutical development and manufacturing, which has made him a globally recognized technical expert in the field.

One common denominator for his work has been to use his business and quality mindset in combination with a broad perspective on biomanufacturing, to support all stages of development and the full supply chain of high-quality pharmaceuticals. This includes experience in addressing the areas critical for commercial manufacturing during the process development and subsequent scale-up stages, as well as handling drug product operations and distribution aspects.

Morten holds a position as Director, Global Alliance Management at FUJIFILM Diosynth Biotechnologies (FDB), supporting the strategic partnership collaboration with several of FDB’s key partners.

Before joining FDB in 2020, Morten worked at NNE as a Global Technology Partner since 2015. In 2001 he co-founded CMC Biologics (now AGC Biologics), after working for 14 years at Novo Nordisk.

Morten is active in the biopharmaceutical community as a member of scientific committees for various international conferences and as a volunteer in international industry organizations such as PDA, ISPE, and BPOG. Moreover, Morten has served as Chair of PDA Biotechnology Advisory Board and is a member of the Advisory Board for Master Studies at Copenhagen University.